TRAIL, a New Weapon against Neointimal Hyperplasia

Publisher： Karger

E-ISSN： 1421-9751|123|2|94-96

ISSN： 0008-6312

Source： Cardiology, Vol.123, Iss.2, 2012-09, pp. : 94-96

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A New Arteriovenous Fistula Model to Study the Development of Neointimal Hyperplasia

By  

Journal of Vascular Research, Vol. 49, Iss. 2, 2012-01 ,pp. : 123-131

Karger

Access to resources Recommend Favorite

Inverse Association of Coronary Soluble Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (sTRAIL) Levels to In-Stent Neointimal Hyperplasia

By  

Cardiology, Vol. 123, Iss. 2, 2012-09 ,pp. : 97-102

Karger

Access to resources Recommend Favorite

Posaconazole: A New Antifungal Weapon

By  

Reviews on Recent Clinical Trials, Vol. 6, Iss. 3, 2011-09 ,pp. : 204-219

Bentham Science Publishers

Access to resources Recommend Favorite

Gliotoxin Inhibits Neointimal Hyperplasia after Vascular Injury in Rats

By  

Journal of Vascular Research, Vol. 46, Iss. 4, 2008-11 ,pp. : 278-289

Karger

Access to resources Recommend Favorite

Neointimal Hyperplasia after Stenting in a Human Mammary Artery Organ Culture

By  

Journal of Vascular Research, Vol. 41, Iss. 1, 2004-02 ,pp. : 46-53

Karger

Access to resources Recommend Favorite